Trial Details
TERMINATEDBasic Information
| Clinical ID | c3197 |
|---|---|
| Identifier | NCT02405442 |
| Trial Title | Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Andecaliximab|DRUG: Placebo |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-04-30 |
|---|---|
| Primary Completion Date | 2016-11-30 |
| Completion Date | 2016-12-22 |